• AML: add-on nivolumab safe, effective with standard induction therapy

    Median EFS not reached at time of analysis.

  • Breast cancer: dose reduction tied to poorer survival with adjuvant FEC-D

    Effect driven by early dose reductions.

  • NCCN updates adult cancer pain guidelines

    Successful management requires a comprehensive, multimodal approach.

  • NICE approves cemiplimab for cutaneous squamous cell carcinoma

    While more mature data is awaited, the treatment will be available within the Cancer Drugs Fund

  • Consensus report: contrast MRI tops CT for screening cirrhotic livers

    Eighth International Forum for Liver MRI yields 20 consensus statements.

  • Mastectomy: immediate breast reconstruction OK before chemotherapy

    Delay in adjuvant chemotherapy found clinically insignificant.

  • Frontline AML: real-world data confirm decitabine safety, efficacy

    Adverse cytogenetics, higher WBC predicted inferior survival.

  • NSCLC: lower cardiac dose constraints needed for radiation treatment

    One in 4 patients receive doses of more than 20 Gy.

  • Thyroid cancer: comorbidities significantly impact mortality risk

    Comorbidities are a larger factor than the malignancy itself.

  • High-risk patients show low interest in lung cancer screening

    More education needed to support informed patient decision-making.

  • Stage IIIC endometrial cancer: chemotherapy first is better than concurrent CRT

    Data show better survival with sequential adjuvant therapy.

  • Lancet Group announces gender equity and diversity pledge
    Lancet Group announces gender equity and diversity pledge

    It is encouraging publishers, journals and members of the science community to contribute to these pledges.

  • Replacing red meat with poultry could cut the risk of breast cancer
    Replacing red meat with poultry could cut the risk of breast cancer

    There was no association of breast cancer with meat mutagens and meat cooking practices.

  • Suspected PE in cancer: ACP's guidelines for noncancer patients perform well

    The presence of cancer shouldn't in itself trigger a CT, say the authors.

  • Load more